<乌鸦传媒>Potassium Acid Blocker No Better Than PPI for Artificial Gastric Ulcers Small Japanese trial found similar outcomes with both drugs May 25, 2021
<乌鸦传媒>GI Disruption Lasts for Months in Many COVID Survivors Persistently loose stools were most common after-effect May 24, 2021
<乌鸦传媒>Microbiome Therapies for Recurrent C. Diff Advance Clinical trial success for two proprietary bacteria mixtures May 22, 2021
<乌鸦传媒>These Risk Factors Can Make Severe Pancreatitis Worse Not surprisingly, clinical outcomes also suffered May 20, 2021
<乌鸦传媒>Probiotics Protect Overweight, Older Patients From Coughs and Wheeze Trial affirms "gut-lung" link but with important caveats May 14, 2021
<乌鸦传媒>Adding GLP-1 Drug Makes Sleeve Gastroplasty a Diabetes Treatment Endoscopic procedure could yield benefits now seen only with more invasive surgery May 14, 2021
<乌鸦传媒>Pandemic Drinking Took Swift Toll on the Gut, Liver Alcohol-related inpatient consults soared, remained high even after reopening May 14, 2021
<乌鸦传媒>Is Dynamic AFP-R Key to Transplant Selection in Liver Cancer? Dynamic alpha-fetoprotein response improved prediction of patient outcomes May 05, 2021
<乌鸦传媒>Results Disappoint for Fecal Transplant in Arthritis But interest persists in targeting the gut-joint axis in psoriatic arthritis May 04, 2021
<乌鸦传媒>'It's a Straw-Man Argument': What We Heard This Week Quotable quotes from 乌鸦传媒's sources May 02, 2021
<乌鸦传媒>New Option for Eosinophilic Esophagitis? Special budesonide formulation topped placebo across a range of outcomes Apr 21, 2021
<乌鸦传媒>Can an Agile Endoscopic Device Curb PPI-Dependent GERD? GERDx device improved quality of life; not so much for esophageal acid exposure Apr 16, 2021
<乌鸦传媒>Perianal Involvement in Crohn鈥檚 Disease: How Bad for Prognosis? Poor outcomes noted, especially with severe phenotype Apr 14, 2021
<乌鸦传媒>Another FGFR Inhibitor Active in Bile Duct Cancers Clinical benefit rate of 82% in patients selected for FGFR2 fusions, rearrangements Apr 13, 2021
<乌鸦传媒>Can a COX-2 Inhibitor Boost Disease-free Survival in CRC? Large trial tested addition of the agent to standard FOLFOX Apr 06, 2021
<乌鸦传媒>Refractory IBD: The Case for Doubling Up on Drugs Meta-analysis suggests select patients can avoid surgery Apr 01, 2021
<乌鸦传媒>Minimizing the Pesky Placebo Response in IBS Trials Identifying the determinants is key to better trial design Mar 26, 2021
<乌鸦传媒>No Help From Extra Hydration to Prevent Post-ERCP Pancreatitis Trial may settle whether aggressive, laborious procedure is justified Mar 18, 2021
<乌鸦传媒>Game Changer for Ulcerative Colitis Patients Failing Anti-TNF? JAK inhibitor helped when biologic didn't Mar 12, 2021
<乌鸦传媒>New Guideline Lowers Age to Begin Colorectal Cancer Screening Update comes as incidence has doubled in people under 50 Mar 09, 2021
<乌鸦传媒>Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis But positive association versus TNF inhibitors not seen in Crohn's disease Mar 01, 2021
<乌鸦传媒>Antibiotic Duo Wins in Diverticulitis Outpatient Tx Less risk for harms without adversely affecting outcomes, cohort studies show Feb 22, 2021
<乌鸦传媒>AGA Updates Guidelines for Refractory H. Pylori New info stresses knowing patients' antibiotic exposure and doing drug susceptibility testing Feb 01, 2021
<乌鸦传媒>JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
<乌鸦传媒>IBD and COVID: Kids Do Well International registry shows older age, comorbidities are risks; anti-TNF might protect Jan 25, 2021
<乌鸦传媒>Aspirin and CRC Risk: A Curious Age Connection Implications for prophylactic recommendations, researchers say Jan 21, 2021
<乌鸦传媒>Drug Hits Target in Advanced Biliary Cancer Responses in up to a third of patients with FGFR inhibitor infigratinib Jan 19, 2021
<乌鸦传媒>New Target to Attack in Stomach Cancer PFS, OS improved with fibroblast growth factor receptor inhibitor in non-HER2 disease Jan 16, 2021
<乌鸦传媒>Gut Microbiome and COVID-19 Severity: New Evidence for Link Lab study finds certain patterns associated with more serious illness Jan 11, 2021
<乌鸦传媒>COVID-19: A Clear Affinity for the Digestive System GI manifestations may be a red flag for more severe disease and worse outcomes Jan 04, 2021
<乌鸦传媒>Diet Curbs GERD Beyond Acid Suppressants Study finds five anti-reflux behaviors could prevent almost 40% of the symptoms in women Jan 04, 2021
<乌鸦传媒>Laparoscopic Lavage a Safe Option in Perforated Diverticulitis No difference versus resection in long-term severe complications, but recurrence more common Dec 29, 2020
<乌鸦传媒>GI Bleeds Tied to Worse Prognosis for COVID-19 Inpatients Anticoagulation or antiplatelet agents not tied to higher risk of bleeding in cohort study Dec 22, 2020
<乌鸦传媒>Young-Onset Esophageal Cancer Rapidly Increasing Physicians should be on the alert for younger patients with dysphagia, researchers urge Dec 16, 2020
<乌鸦传媒>IBD and COVID-19: Who Is at Risk? Worse outcomes for older patients and those with comorbidities and on steroids Dec 12, 2020
<乌鸦传媒>Can Some Treatments Be Stopped in IBD? With combination therapy, some patients successfully withdrew the TNF inhibitor Dec 11, 2020
<乌鸦传媒>Ozanimod a Winner in Ulcerative Colitis S1P receptor modulator effective for both induction and maintenance Dec 10, 2020
